National safety data of post-marketing use of omalizumab in severe persistent asthma in Turkey

Please use this identifier to cite or link to this item: http://hdl.handle.net/11452/25149

Title:	National safety data of post-marketing use of omalizumab in severe persistent asthma in Turkey
Authors:	Dursun, Adile Berna Bavbek, Sevim Mısırlıgil, Zeynep Erdener, F. Büyüköztürk, Suna Aydın, Ömür Gemicioğlu, Bilun Bayrak, P. Erkekol, Ferda Öner Yıldırım, Zeki Çilli, Aykut Boz, Bingol A. Alpaydın, Özgen A. Karakoç, Bingol G. Görgüner, Metin Karakaya, Gül Işık, Rüveyda Bakırtaş, Arzu Uludağ Üniversitesi/Tıp Fakültesi/Çocuk Sağlığı ve Hastalıkları Anabilim Dalı. Sapan, Nihat
Keywords:	Allergy Immunology
Issue Date:	Jun-2011
Publisher:	Wiley
Citation:	Dursun, A. vd. (2011). "National safety data of post-marketing use of omalizumab in severe persistent asthma in Turkey". Allergy, 66(Supplement 94), Special Issue SI, 675-676.
Description:	Bu çalışma, 11-15 Haziran 2011 tarihleri arasında İstanbul[Türkiye]’da düzenlenen 30th Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI)’da bildiri olarak sunulmuştur.
URI:	http://hdl.handle.net/11452/25149
ISSN:	0105-4538 1398-9995
Appears in Collections:	Web of Science

Files in This Item:

There are no files associated with this item.

DSpace JSPUI